JNCE

Jounce Therapeutics, Inc. Common Stock
JNCE

Overview Fund Activity
Delisted

JNCE was delisted on the 3rd of May, 2023.

Back to rankings

124 hedge funds and large institutions have $378M invested in Jounce Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 32 increasing their positions, 32 reducing their positions, and 20 closing their positions.

Holders
124
Holders Change
+20
Holders Change %
+19.23%
% of All Funds
2.18%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
40
Increased
32
Reduced
32
Closed
20
Calls
$596K
Puts
$3.22M
Net Calls
-$2.63M
Net Calls Change
-$2.25M

Top Buyers

1
PHS
1
PFM Health Sciences
California
$33.5M
2
Victory Capital Management
2
Victory Capital Management
Texas
$24.1M
3
O
3
OrbiMed
New York
$18.7M
4
CCM
4
CAAS Capital Management
New York
$10.8M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$24.9M

Top Sellers

1
TGI
1
TRV GP II
Massachusetts
$66.8M
2
WP
2
Woodline Partners
California
$0
3
SI
3
Sofinnova Investments
California
$5.26M
4
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$111K
5
Verition Fund Management
5
Verition Fund Management
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
TGI
1
TRV GP II
Massachusetts
$66.8M 6,500,349 -2,700,000 -29%
PHS
2
PFM Health Sciences
California
$33.5M 3,262,833 +3,262,833 New
TGI
3
TRV GP III
Massachusetts
$31.3M 3,048,780 – –
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$24.9M 2,428,023 +956,023 +65%
Victory Capital Management
5
Victory Capital Management
Texas
$24.1M 2,342,005 +2,342,005 New
Citadel Advisors
6
Citadel Advisors
Florida
$20.1M 1,960,547 +229,198 +13%
BlackRock
7
BlackRock
New York
$18.9M 1,839,299 +292,744 +19%
O
8
OrbiMed
New York
$18.7M 1,823,600 +1,823,600 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$14M 1,360,765 +459,705 +51%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$10.9M 1,060,431 -116,642 -10%
CCM
11
CAAS Capital Management
New York
$10.8M 1,052,437 +1,052,437 New
Fidelity Investments
12
Fidelity Investments
Massachusetts
$7.61M 741,034 +623,260 +529%
EAM
13
Erste Asset Management
Austria
$6.49M 634,587 +50,000 +9%
ACA
14
Avoro Capital Advisors
New York
$5.7M 555,000 +555,000 New
ACM
15
Asymmetry Capital Management
California
$5.35M 520,858 +520,858 New
SI
16
Sofinnova Investments
California
$5.26M 511,822 -413,458 -45%
CS
17
Credit Suisse
Switzerland
$5.18M 504,583 +504,583 New
Acadian Asset Management
18
Acadian Asset Management
Massachusetts
$4.98M 485,145 -67,483 -12%
TCM
19
Tekla Capital Management
Massachusetts
$3.93M 382,237 +382,237 New
SCM
20
Silverarc Capital Management
Massachusetts
$3.6M 350,000 -56,665 -14%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$3.52M 342,525 +75,218 +28%
GIM
22
Granahan Investment Management
Massachusetts
$3.48M 338,969 -61,044 -15%
State Street
23
State Street
Massachusetts
$3.15M 306,279 -22,427 -7%
OFM
24
Omega Fund Management
Massachusetts
$2.83M 275,513 -59,452 -18%
Northern Trust
25
Northern Trust
Illinois
$2.59M 252,600 -61,040 -19%
1
2 3 4 5